rs756844729

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_004484.4(GPC3):​c.761G>T​(p.Arg254Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000237 in 1,097,750 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R254Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000024 ( 0 hom. 14 hem. )
Failed GnomAD Quality Control

Consequence

GPC3
NM_004484.4 missense

Scores

5
10
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 7.51

Publications

0 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-133753753-C-A is Benign according to our data. Variant chrX-133753753-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 476666.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000237 (26/1097750) while in subpopulation SAS AF = 0.000425 (23/54140). AF 95% confidence interval is 0.00029. There are 0 homozygotes in GnomAdExome4. There are 14 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 14 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPC3NM_004484.4 linkc.761G>T p.Arg254Leu missense_variant Exon 3 of 8 ENST00000370818.8 NP_004475.1 P51654-1Q53H15I6QTG3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPC3ENST00000370818.8 linkc.761G>T p.Arg254Leu missense_variant Exon 3 of 8 1 NM_004484.4 ENSP00000359854.3 P51654-1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
111964
Hom.:
0
Cov.:
23
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000328
AC:
6
AN:
182851
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000237
AC:
26
AN:
1097750
Hom.:
0
Cov.:
33
AF XY:
0.0000386
AC XY:
14
AN XY:
363114
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26399
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19383
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.000425
AC:
23
AN:
54140
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40533
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841673
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
111964
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34124
African (AFR)
AF:
0.00
AC:
0
AN:
30800
American (AMR)
AF:
0.00
AC:
0
AN:
10569
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3576
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2680
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6080
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53182
Other (OTH)
AF:
0.00
AC:
0
AN:
1504
Alfa
AF:
0.0000508
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Nov 10, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Wilms tumor 1 Benign:1
Aug 01, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.78
BayesDel_addAF
Uncertain
0.16
D
BayesDel_noAF
Pathogenic
0.28
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.57
D;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Pathogenic
0.57
D
MetaRNN
Uncertain
0.72
D;D;D
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.5
M;M;.
PhyloP100
7.5
PrimateAI
Uncertain
0.72
T
PROVEAN
Pathogenic
-6.7
D;D;.
REVEL
Uncertain
0.58
Sift
Uncertain
0.0020
D;D;.
Sift4G
Uncertain
0.0030
D;D;D
Polyphen
0.95
P;.;.
Vest4
0.84
MutPred
0.83
Loss of MoRF binding (P = 0.0024);Loss of MoRF binding (P = 0.0024);.;
MVP
0.93
MPC
0.69
ClinPred
0.63
D
GERP RS
5.0
PromoterAI
0.015
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.89
gMVP
0.90
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756844729; hg19: chrX-132887780; API